Alvan Feinstein was an American clinician, health informatician, and epidemiologist who had a significant impact on clinical investigation, especially in the field of clinical epidemiology that he helped define.
14 Facts About Alvan Feinstein
1.
2.
Alvan Feinstein is regarded as one of the fathers of modern clinical epidemiology.
3.
Feinstein was born in Philadelphia, Feinstein received his bachelor's degree and master's degree in mathematics at the University of Chicago.
4.
Alvan Feinstein received his medical degree at the University of Chicago School of Medicine.
5.
Alvan Feinstein completed his residency training in Internal Medicine at Rockefeller Institute.
6.
Alvan Feinstein demonstrated that the disease had different forms including one which causes joint pain and seldom progresses to heart disease.
7.
In 1962, Alvan Feinstein joined the Yale University School of Medicine faculty and became the founding director of its Robert Wood Johnson Clinical Scholars Program in 1974.
8.
Alvan Feinstein was widely known for his gift for mentoring, bringing passion to academic medicine and the art of becoming an academic.
9.
Alvan Feinstein published his first paper as a medical student in 1951 and more than 400 throughout his career.
10.
Alvan Feinstein wrote six major textbooks, two of which, Clinical Judgment and Clinical Epidemiology: The Architecture of Clinical Research are among the most widely referenced books in clinical epidemiology.
11.
Alvan Feinstein completed the last one, Principles of Medical Statistics, just before his death.
12.
In 1991, Alvan Feinstein was named the Sterling Professor of Medicine and Epidemiology, Yale University's most prestigious academic honor.
13.
Alvan Feinstein was funded by the Council for Tobacco Research, established by the tobacco industry to attack scientific studies that put tobacco in a bad light, as early as 1964.
14.
Yacht and Bialous claim a commentary Alvan Feinstein published in 1992 in Toxicologic Pathology defended the tobacco industry but failed to mentioned he received grant funding from the tobacco industry.